In in vitro assays, ENMD-1198 substantially abrogated EGF- and HGF-mediated cancer cell migration and invasiveness, suggesting that this substance could be valuable for reducing HCC metastasis. The gene discussed is EGF; the disease is hepatocellular carcinoma.